Abstract: Pharmaceutical composition comprising a combination of a proton pump inhibitor, preferably rebeprazole sodium with domperidone for the treatment of GERD and other GI disorders are disclosed. Rabeprazole is in enteric coated form, while domperidone is in dual release forms of immediate and pH independent sutained release, to give a 24 hour release profile. The individual compositions are suitably formulated as tablets to achieve desired release profiles, which are then prefilled into hard gelatin capsules using a pharmaceutically acceptable filling aid.
| # | Name | Date |
|---|---|---|
| 1 | 775-MUM-2004-FORM 4(23-10-2012).pdf | 2012-10-23 |
| 2 | 775-MUM-2004-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(23-10-2012).pdf | 2012-10-23 |
| 3 | 775-MUM-2004-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(28-06-2013).pdf | 2013-06-28 |
| 4 | 775-MUM-2004-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(29-12-2015).pdf | 2015-12-29 |
| 5 | 248777-FORM 4-22-01-2018.pdf | 2018-01-22 |
| 6 | 248777-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-22-01-2018.pdf | 2018-01-22 |
| 7 | 775-MUM-2004_EXAMREPORT.pdf | 2018-08-09 |
| 8 | 775-MUM-2004-REPLY TO HEARING(15-2-2011).pdf | 2018-08-09 |
| 9 | 775-MUM-2004-OTHER DOCUMENT(15-2-2011).pdf | 2018-08-09 |
| 10 | 775-MUM-2004-FORM 5(23-3-2009).pdf | 2018-08-09 |
| 11 | 775-MUM-2004-FORM 5(21-7-2004).pdf | 2018-08-09 |
| 12 | 775-MUM-2004-FORM 5(20-7-2005).pdf | 2018-08-09 |
| 13 | 775-MUM-2004-FORM 3(23-3-2009).pdf | 2018-08-09 |
| 14 | 775-MUM-2004-FORM 26(13-9-2005).pdf | 2018-08-09 |
| 15 | 775-MUM-2004-FORM 2(TITLE PAGE)-(PROVISIONAL)-(21-7-2004).pdf | 2018-08-09 |
| 16 | 775-MUM-2004-FORM 2(TITLE PAGE)-(GRANTED)-(24-8-2011).pdf | 2018-08-09 |
| 17 | 775-MUM-2004-FORM 2(TITLE PAGE)-(23-3-2009).pdf | 2018-08-09 |
| 18 | 775-MUM-2004-FORM 2(TITLE PAGE)-(20-7-2005).pdf | 2018-08-09 |
| 19 | 775-MUM-2004-FORM 2(PROVISIONAL)-(21-7-2004).pdf | 2018-08-09 |
| 20 | 775-MUM-2004-FORM 2(GRANTED)-(24-8-2011).pdf | 2018-08-09 |
| 21 | 775-MUM-2004-FORM 2(COMPLETE)-(20-7-2005).pdf | 2018-08-09 |
| 22 | 775-mum-2004-form 2(23-3-2009).pdf | 2018-08-09 |
| 23 | 775-MUM-2004-FORM 18(8-2-2007).pdf | 2018-08-09 |
| 24 | 775-MUM-2004-FORM 13(12-3-2008).pdf | 2018-08-09 |
| 25 | 775-MUM-2004-FORM 13(10-1-2011).pdf | 2018-08-09 |
| 26 | 775-MUM-2004-FORM 1(23-3-2009).pdf | 2018-08-09 |
| 27 | 775-MUM-2004-FORM 1(21-7-2004).pdf | 2018-08-09 |
| 28 | 775-MUM-2004-DRAWING(GRANTED)-(24-8-2011).pdf | 2018-08-09 |
| 29 | 775-MUM-2004-DRAWING(23-3-2009).pdf | 2018-08-09 |
| 30 | 775-MUM-2004-DESCRIPTION(PROVISIONAL)-(21-7-2004).pdf | 2018-08-09 |
| 31 | 775-MUM-2004-DESCRIPTION(GRANTED)-(24-8-2011).pdf | 2018-08-09 |
| 32 | 775-MUM-2004-DESCRIPTION(COMPLETE)-(23-3-2009).pdf | 2018-08-09 |
| 33 | 775-MUM-2004-DESCRIPTION(COMPLETE)-(20-7-2005).pdf | 2018-08-09 |
| 34 | 775-MUM-2004-CORRESPONDENCE(IPO)-(24-8-2011).pdf | 2018-08-09 |
| 35 | 775-MUM-2004-CORRESPONDENCE(6-4-2010).pdf | 2018-08-09 |
| 36 | 775-MUM-2004-CORRESPONDENCE(23-3-2009).pdf | 2018-08-09 |
| 37 | 775-MUM-2004-CORRESPONDENCE(12-3-2008).pdf | 2018-08-09 |
| 38 | 775-MUM-2004-CORRESPONDENCE(10-1-2011).pdf | 2018-08-09 |
| 39 | 775-MUM-2004-CLAIMS(GRANTED)-(24-8-2011).pdf | 2018-08-09 |
| 40 | 775-MUM-2004-CLAIMS(AMENDED)-(6-4-2010).pdf | 2018-08-09 |
| 41 | 775-MUM-2004-CLAIMS(AMENDED)-(23-3-2009).pdf | 2018-08-09 |
| 42 | 775-MUM-2004-CLAIMS(AMENDED)-(15-2-2011).pdf | 2018-08-09 |
| 43 | 775-MUM-2004-CLAIMS(23-3-2009).pdf | 2018-08-09 |
| 44 | 775-MUM-2004-CLAIMS(20-7-2005).pdf | 2018-08-09 |
| 45 | 775-MUM-2004-CANCELLED PAGES(15-2-2011).pdf | 2018-08-09 |
| 46 | 775-MUM-2004-ABSTRACT(GRANTED)-(24-8-2011).pdf | 2018-08-09 |
| 47 | 775-MUM-2004-ABSTRACT(20-7-2005).pdf | 2018-08-09 |
| 48 | 248777-Correspondence-220620.pdf | 2020-06-24 |
| 49 | 248777-Correspondence (Renewal)-220620.pdf | 2020-06-24 |
| 50 | 248777-Form 30-190721.pdf | 2021-10-02 |
| 51 | 248777-Correspondence-190721.pdf | 2021-10-02 |
| 52 | 248777-Form 30-200722.pdf | 2022-07-21 |
| 53 | 248777-Correspondence-200722.pdf | 2022-07-21 |